Would you like to participate ask a question join the surfers in our next episode?

COVID-19 and Fatty Liver: What We Know in 2021

Manal Abdelmalek joins the Surfers to discuss how recent COVID-19 news might affect Fatty Liver patients and what the medical profession and BioPharma companies can do to support patients better during this dangerous phase of the pandemic.


Manal Abdelmalek joins the Surfers to discuss the implications of the new British COVID-19 variant, availability of the Pfizer/BioNTech and Moderna vaccines and impact of social distancing on patients with Fatty Liver Disease. The discussion starts by surveying the current situation and goes on to discuss challenges for patients and provider and then keys to maximum success in conducting clinical trials and treating patients. In the end, Stephen Harrison and Roger Green propose big, bold solutions to improve diagnosis and patient care.


 

Request Transcript of This Episode
Request Transcript
First
Last

NASH & Diabetes Podcast and NASH Tsunami Podcast